Trial intelligence / Profile preview

Perioperative Intravenous Magnesium for Pain After ESD

NCT02235246Phase 4Completed

Sponsor
Yonsei University
Start
Oct 2014
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of magnesium sulfate in gastric cancer (GC) (2 arms), sponsored by Yonsei University. Primary endpoint: Pain Score at 24 hours. Started Oct 2014; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT02235246.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02235246.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call